Must identify = need all 4: |
1. A photodistributed rash as a result of UVR exposure after drug initiation (or other known SJS/TEN cause) |
2. Rash progression/worsening > 48 h to include vesicles/bullae and/or sloughing of the epidermis |
3. Negative direct immunofluorescence |
4. More likely SJS/TEN than erythema multiforme |
Major criteria (should identify) = need 3/4: |
1. A causal drug |
2. Mucous membrane involvement |
3. Positive Nikolsky sign |
4. Histopathology demonstrating full-thickness epidermal necrosis with subepidermal bullae development |
Minor criteria (common findings) = need 2/4: |
1. Palmar and plantar rash |
2. Delayed rash onset that presents no earlier than the day after UVR exposure |
3. Satellite lesions/non-discrete borders on UVR protected (clothing covered) skin |
4. No flu-like prodrome |